FR2912059B1 - USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE - Google Patents

USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE

Info

Publication number
FR2912059B1
FR2912059B1 FR0700821A FR0700821A FR2912059B1 FR 2912059 B1 FR2912059 B1 FR 2912059B1 FR 0700821 A FR0700821 A FR 0700821A FR 0700821 A FR0700821 A FR 0700821A FR 2912059 B1 FR2912059 B1 FR 2912059B1
Authority
FR
France
Prior art keywords
argiles
treatment
celiac disease
celiac
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0700821A
Other languages
French (fr)
Other versions
FR2912059A1 (en
Inventor
Fortunet Helene Mathiex
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Consumer Healthcare Fr
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0700821A priority Critical patent/FR2912059B1/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to US12/525,886 priority patent/US20100003348A1/en
Priority to CN2008800040482A priority patent/CN101605551B/en
Priority to PCT/FR2008/000142 priority patent/WO2008113905A1/en
Priority to EP08761845.0A priority patent/EP2117566B1/en
Priority to ES08761845.0T priority patent/ES2610816T3/en
Priority to CA2677404A priority patent/CA2677404C/en
Priority to BRPI0807467-4A2A priority patent/BRPI0807467A2/en
Priority to JP2009548713A priority patent/JP2010518054A/en
Priority to MX2009008040A priority patent/MX2009008040A/en
Priority to RU2009133350/15A priority patent/RU2519217C2/en
Priority to ARP080100519A priority patent/AR065215A1/en
Publication of FR2912059A1 publication Critical patent/FR2912059A1/en
Priority to US13/446,238 priority patent/US20130039999A1/en
Application granted granted Critical
Publication of FR2912059B1 publication Critical patent/FR2912059B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
FR0700821A 2007-02-06 2007-02-06 USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE Active FR2912059B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0700821A FR2912059B1 (en) 2007-02-06 2007-02-06 USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE
RU2009133350/15A RU2519217C2 (en) 2007-02-06 2008-02-06 Using clays for treating celiac disease
PCT/FR2008/000142 WO2008113905A1 (en) 2007-02-06 2008-02-06 Use of clay for treating coeliac disease
EP08761845.0A EP2117566B1 (en) 2007-02-06 2008-02-06 Use of clay for treating coeliac disease
ES08761845.0T ES2610816T3 (en) 2007-02-06 2008-02-06 Use of clays for the treatment of celiac disease
CA2677404A CA2677404C (en) 2007-02-06 2008-02-06 Use of clay for treating coeliac disease
US12/525,886 US20100003348A1 (en) 2007-02-06 2008-02-06 Use of clays for treating coeliac disease
JP2009548713A JP2010518054A (en) 2007-02-06 2008-02-06 Use of clay to treat celiac disease
MX2009008040A MX2009008040A (en) 2007-02-06 2008-02-06 Use of clay for treating coeliac disease.
CN2008800040482A CN101605551B (en) 2007-02-06 2008-02-06 Use of a clay to prepare a medicament for treating or preventing coeliac disease
ARP080100519A AR065215A1 (en) 2007-02-06 2008-02-06 USE OF CLAYS FOR THE TREATMENT OF CELIAC DISEASE
BRPI0807467-4A2A BRPI0807467A2 (en) 2007-02-06 2008-02-06 USE OF A CLAY
US13/446,238 US20130039999A1 (en) 2007-02-06 2012-04-13 Use of clays for treating coeliac disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700821A FR2912059B1 (en) 2007-02-06 2007-02-06 USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE

Publications (2)

Publication Number Publication Date
FR2912059A1 FR2912059A1 (en) 2008-08-08
FR2912059B1 true FR2912059B1 (en) 2013-04-05

Family

ID=38515715

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0700821A Active FR2912059B1 (en) 2007-02-06 2007-02-06 USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE

Country Status (12)

Country Link
US (2) US20100003348A1 (en)
EP (1) EP2117566B1 (en)
JP (1) JP2010518054A (en)
CN (1) CN101605551B (en)
AR (1) AR065215A1 (en)
BR (1) BRPI0807467A2 (en)
CA (1) CA2677404C (en)
ES (1) ES2610816T3 (en)
FR (1) FR2912059B1 (en)
MX (1) MX2009008040A (en)
RU (1) RU2519217C2 (en)
WO (1) WO2008113905A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
DE102012207471A1 (en) * 2012-05-04 2013-11-07 Fim Biotech Gmbh Mineral compound and its modifications for use in inflammatory bowel disease
US9836879B2 (en) * 2013-04-16 2017-12-05 Autodesk, Inc. Mesh skinning technique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
RU2106861C1 (en) * 1991-01-30 1998-03-20 Дзе Веллкам Фаундейшн Лимитед Water-dispersible tablets, method for theri preparing, and granules and dispersing agent for their production
CN1326745A (en) * 2000-06-01 2001-12-19 翟永功 Montmorillonite as component of gastrointestinal tract medicine
DE10056634A1 (en) * 2000-11-15 2002-05-29 Sued Chemie Ag Use of activated layered silicates for mycotoxin adsorption
CN100340235C (en) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 Montmorillonite dispersed tablet and preparation technique thereof

Also Published As

Publication number Publication date
US20130039999A1 (en) 2013-02-14
WO2008113905A1 (en) 2008-09-25
RU2009133350A (en) 2011-03-20
EP2117566B1 (en) 2016-10-19
BRPI0807467A2 (en) 2014-05-20
CA2677404C (en) 2015-07-07
MX2009008040A (en) 2009-08-07
AR065215A1 (en) 2009-05-20
CA2677404A1 (en) 2008-09-25
FR2912059A1 (en) 2008-08-08
CN101605551B (en) 2013-04-03
US20100003348A1 (en) 2010-01-07
RU2519217C2 (en) 2014-06-10
ES2610816T3 (en) 2017-05-03
CN101605551A (en) 2009-12-16
EP2117566A1 (en) 2009-11-18
JP2010518054A (en) 2010-05-27

Similar Documents

Publication Publication Date Title
FR2902324B1 (en) USE OF ELLAGIC ACID FOR THE TREATMENT OF CANITIA
FR2867961B1 (en) RETRACTABLE TREATMENT INSTRUMENT FOR AN ENDOSCOPE
FR2920305B1 (en) USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS.
FR2948016B1 (en) ORTHESIS FOR THE TREATMENT OF RHIZARTHROSIS
FR2907011B1 (en) USE OF CITRULLINE FOR THE TREATMENT OF DENUTRITION CONDITIONS
FR13C0030I1 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
FR2915102B1 (en) USE OF ANTI-CXCR4 ANTIBODY FOR THE TREATMENT OF CANCER
FR2912761B1 (en) PROTHETIC KNIT FOR THE TREATMENT OF PROLAPSUS
FR2897533B1 (en) OXIDIZING AGENT FOR THE TREATMENT OF HAIR
FR2906468B1 (en) USE OF COMPOUNDS OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
FR2918282B1 (en) MEDICINE FOR THE TREATMENT OF PARKINSON'S DISEASE
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
FR2899128B1 (en) USE OF DELEUCOCYTATION FILTERS FOR THE PURIFICATION OF DEFENSINS
FR2954124B1 (en) USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR THE TREATMENT OF SEBORRHEA
FR2902320B1 (en) USE OF BUTYLATED HYDROXYANISOLE FOR THE TREATMENT OF CANITIA
FR2912059B1 (en) USE OF ARGILES FOR THE TREATMENT OF CELIAC DISEASE
FR2924593B1 (en) BONE PLATE FOR THE TREATMENT OF THE LOWER END OF THE CUBITUS
FR2910813B1 (en) NEW THERAPEUTIC USE FOR THE TREATMENT OF LEUKEMIA
FR2915098B1 (en) USE OF 4-CYCLOPROPYLMETHOXY-N- (3,5-DICHLORO-1-OXYDO-PYRIDIN-4-YL) -5- (METHOXY) PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF TRAUMATISMS OF SPINAL CORD
FR2906469B1 (en) USE OF COMPOUNDS OF THE AVERMECTIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2868307B1 (en) USE OF BETA-ENDORPHINE FOR THE TREATMENT OF WRINKLES
FR2918281B1 (en) MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE.
FR2906466B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN
FR2906467B1 (en) USE OF COMPOUNDS FROM THE MILBEMYCIN FAMILY FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS IN MAN

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

TP Transmission of property

Owner name: IPSEN CONSUMER HEALTHCARE, FR

Effective date: 20210706

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18